← back to search

David M. White

University of Alabama at Birmingham · US
Area of research
Cognitive Neuroscience · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Schizophrenia (object-oriented programming), Neuroscience, Psychology, Anterior cingulate cortex, Risperidone, and Glutamate receptor.
h-index
citations
2,762
works
50
NIH funding
primary concept
email

Recent publications

Pain Coping Skills Training for Patients Receiving Hemodialysis
JAMA Internal Medicine 2024cited by 23position: middledoi
Adolescent driving behavior before and during restrictions related to COVID-19
Accident Analysis & Prevention 2020cited by 90position: lastdoi
Patient and Caregiver Perspectives on Terms Used to Describe Kidney Health
Clinical Journal of the American Society of Nephrology 2020cited by 60position: middledoi
A Prospective Longitudinal Investigation of Cortical Thickness and Gyrification in Schizophrenia
The Canadian Journal of Psychiatry 2020cited by 38position: middledoi
A longitudinal neurite and free water imaging study in patients with a schizophrenia spectrum disorder
Neuropsychopharmacology 2019cited by 56position: middledoi
A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia
Schizophrenia Research 2019cited by 49position: middledoi
Micro- and Macrostructural White Matter Integrity in Never-Treated and Currently Unmedicated Patients With Schizophrenia and Effects of Short-Term Antipsychotic Treatment
Biological Psychiatry Cognitive Neuroscience and Neuroimaging 2019cited by 31position: middledoi
T90. NEUROBIOLOGICAL SIGNATURES OF ANTIPSYCHOTIC TREATMENT RESPONSE – A COMBINED MAGNETIC RESONANCE SPECTROSCOPY AND RESTING STATE CONNECTIVITY STUDY IN SCHIZOPHRENIA
Schizophrenia Bulletin 2019cited by 0position: middledoi
234. Hippocampal Glutamate and Resting State Functional Connectivity as Biomarkers of Treatment Response to Antipsychotic Medication
Biological Psychiatry 2019cited by 0position: lastdoi
Relationship Between Cortical Excitation and Inhibition and Task-Induced Activation and Deactivation: A Combined Magnetic Resonance Spectroscopy and Functional Magnetic Resonance Imaging Study at 7T in First-Episode Psychosis
Biological Psychiatry Cognitive Neuroscience and Neuroimaging 2018cited by 41position: middledoi
Evaluation of fronto-striatal networks during cognitive control in unmedicated patients with schizophrenia and the effect of antipsychotic medication
Schizophrenia 2018cited by 39position: middledoi
A Longitudinal Multimodal Neuroimaging Study to Examine Relationships Between Resting State Glutamate and Task Related BOLD Response in Schizophrenia
Frontiers in Psychiatry 2018cited by 39position: middledoi
Four‐way multimodal fusion of 7 <scp>T</scp> imaging data using an m<scp>CCA</scp>+j<scp>ICA</scp> model in first‐episode schizophrenia
Human Brain Mapping 2018cited by 35position: middledoi
Cognitive control network dysconnectivity and response to antipsychotic treatment in schizophrenia
Schizophrenia Research 2018cited by 32position: middledoi
Gyrification Connectomes in Unmedicated Patients With Schizophrenia and Following a Short Course of Antipsychotic Drug Treatment
Frontiers in Psychiatry 2018cited by 22position: middledoi
25.2 UNDERSTANDING WHITE MATTER PATHOLOGY IN SCHIZOPHRENIA USING DIFFUSION TENSOR IMAGING AND MAGNETIC RESONANCE SPECTROSCOPY
Schizophrenia Bulletin 2018cited by 0position: middledoi
T19. MULTIMODAL IMAGING IN FIRST EPISODE PSYCHOSIS: MAGNETOENCEPHALOGRAPHY, 7T FMRI STROOP, AND 7T MRS SPECTROSCOPY
Schizophrenia Bulletin 2018cited by 0position: middledoi
7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia
Schizophrenia Bulletin 2017cited by 114position: middledoi
Risperidone Effects on Brain Dynamic Connectivity—A Prospective Resting-State fMRI Study in Schizophrenia
Frontiers in Psychiatry 2017cited by 48position: middledoi
RETRACTED: Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggests Dentate Gyrus Pathology Linked to N-Methyl-D-Aspartate Receptor Hypofunction
Biological Psychiatry Cognitive Neuroscience and Neuroimaging 2017cited by 32position: middledoi
SA71. A Multimodal Magnetoencephalography, 7T fMRI Stroop, and 7T MRS Spectroscopy Study in First-Episode Psychosis
Schizophrenia Bulletin 2017cited by 1position: middledoi
47. Effect of Antipsychotic Medication on Hippocampal Function and Neurochemistry: A Longitudinal Study in Patients With Schizophrenia
Schizophrenia Bulletin 2017cited by 0position: firstdoi
4.4 Hippocampal Glutamate and Functional Connectivity as Biomarkers of Treatment Response to Antipsychotic Medication
Schizophrenia Bulletin 2017cited by 0position: middledoi
SA85. White Matter Connectivity as a Predictor of Response to Antipsychotic Treatment: A Diffusion Connectometry Study in Unmedicated Patients With Schizophrenia
Schizophrenia Bulletin 2017cited by 0position: middledoi
SA66. A Combined 7T Stroop fMRI and MRS Study in First-Episode Schizophrenia
Schizophrenia Bulletin 2017cited by 0position: middledoi
964. White Matter Integrity, Measured with Diffusion Connectometry, in Unmedicated Patients with Schizophrenia and Response to Antipsychotic Treatment
Biological Psychiatry 2017cited by 0position: middledoi
Change in brain network topology as a function of treatment response in schizophrenia: a longitudinal resting-state fMRI study using graph theory
Schizophrenia 2016cited by 137position: middledoi
Aberrant Hippocampal Connectivity in Unmedicated Patients With Schizophrenia and Effects of Antipsychotic Medication: A Longitudinal Resting State Functional MRI Study
Schizophrenia Bulletin 2016cited by 126position: middledoi
Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers
Molecular Psychiatry 2016cited by 100position: middledoi
SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma
Science Translational Medicine 2015cited by 288position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Adrienne C. Lahti · University of Alabama at Birmingham45 papers (2012–2020)Meredith A. Reid · Auburn University33 papers (2012–2019)Nina V. Kraguljac · Institute for Behavioral Medicine32 papers (2012–2020)Jennifer Ann Hadley · University of Alabama at Birmingham8 papers (2012–2016)Timothy J. Gawne · University of Alabama at Birmingham7 papers (2012–2018)Mark Bolding · University of Alabama at Birmingham Hospital7 papers (2012–2016)Nouha Salibi · Siemens Healthcare (United States)5 papers (2015–2018)Eric Nelson · University of Alabama at Birmingham4 papers (2018–2020)Lawrence Ver Hoef · University of Alabama at Birmingham4 papers (2014–2016)Nathan L. Hutcheson · University of Alabama at Birmingham4 papers (2012–2014)Charity J. Morgan · University of Alabama at Birmingham4 papers (2017–2019)Ripu D. Jindal · University of Alabama at Birmingham4 papers (2018–2020)Kathy B. Avsar · University of Alabama at Birmingham4 papers (2012–2013)Elyse J. Cadena · University of Alabama at Birmingham3 papers (2018–2018)Gregory Overbeek · University of Alabama at Birmingham3 papers (2017–2018)Frank M. Skidmore · University of Alabama at Birmingham3 papers (2013–2019)Karthik Sreenivasan · Alzheimer's Association3 papers (2014–2015)Gopikrishna Deshpande · Indian Institute of Technology Hyderabad3 papers (2014–2015)Jan A. den Hollander · University of Alabama at Birmingham3 papers (2012–2013)Michael A. Frölich · University of Alabama at Birmingham2 papers (2016–2017)